How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Pharma and Healthcare · Forecast 2027–2033
Tissue Forcep Market
- By Material: Stainless Steel, Titanium, Plastic, Aluminum
- By Tip Design: Serrated Tip, Smooth Tip, Toothed Tip, Rat Tooth Tip, Diamond Tip
- By Handle Type: Ring Handle, Spring Handle, Flat Handle, Ergonomic Handle
- By Length: 100 mm, 150 mm, 200 mm, 250 mm, 300 mm
- By Usage: Disposable, Reusable
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Projected to reach $X,XXX.XM by 2033 on sustained demand. Market Outlook →
- 03 Growth - X.XX% CAGR across 2027–2033, with the full year-by-year model inside. Market Outlook →
- 04 Leading segment - Stainless Steel leads By Material at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 293 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.177 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.185 →
Full report · locked preview
Everything inside the Tissue Forcep Market report
A complete, evidence-based study - 12 chapters and 123 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Material 4
Tip Design 5
Handle Type 4
Length 5
Usage 2
Companies profiled
Medtronic
Johnson & Johnson (Ethicon)
B. Braun Melsungen AG
Stryker Corporation
Smith & Nephew
3M Company
ConMed Corporation
Teleflex Incorporated
Integra LifeSciences
Karl Storz SE & Co. KG
Richard Wolf GmbH
Olympus Corporation
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Medtronic
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Johnson & Johnson (Ethicon)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →B. Braun Melsungen AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Stryker Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Smith & Nephew
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →3M Company
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →ConMed Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Teleflex Incorporated
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Integra LifeSciences
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Karl Storz SE & Co. KG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Richard Wolf GmbH
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Olympus Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Aesculap (B. Braun)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Zimmer Biomet
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Cook Medical
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →
Global · 2025–2033
$1,714M by 2033 · 5.0% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Stainless Steel44.3
- Titanium17.7
- Plastic17.4
- Aluminum20.6
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$383.5M → $558.4M · 4.8%
Europe$267.3M → $424.7M · 6.0%
Asia Pacific$244.0M → $332.8M · 4.0%
Latin America$151.1M → $201.9M · 3.7%
Middle East and Africa$116.2M → $153.1M · 3.5%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →4.942026
4.942027
4.952028
4.972029
4.972030
4.992031
5.002032
5.012033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Medtronic8.5
- Johnson & Johnson (Ethicon)22.0
- B. Braun Melsungen AG10.2
- Stryker Corporation10.4
- Smith & Nephew10.8
- 3M Company10.0
- Others28.1
Segment contribution to growth (%)
Fig. 18 · p.39 →Material15.7%
Tip Design23.8%
Handle Type21.1%
Length13.3%
Usage26.1%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America33.4
- Europe25.4
- Asia Pacific19.9
- Latin America12.1
- Middle East and Africa9.2
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Medtronic | 82 | 98 | 95 | 87 | 86 | 99 | 91 |
| Johnson & Johnson (Ethicon) | 79 | 70 | 79 | 74 | 85 | 79 | 78 |
| B. Braun Melsungen AG | 79 | 73 | 63 | 63 | 68 | 63 | 68 |
| Stryker Corporation | 79 | 71 | 63 | 63 | 79 | 76 | 72 |
| Smith & Nephew | 58 | 75 | 66 | 60 | 56 | 73 | 65 |
| 3M Company | 62 | 53 | 51 | 49 | 70 | 61 | 58 |
| ConMed Corporation | 40 | 57 | 56 | 43 | 63 | 63 | 54 |
| Teleflex Incorporated | 38 | 58 | 54 | 50 | 40 | 59 | 50 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Medtronic
- Johnson & Johnson (Ethicon)
- B. Braun Melsungen AG
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Medtronic | ◐ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Johnson & Johnson (Ethicon) | ◐ | ◐ | ◐ | ◐ | ✓ | ✓ |
| B. Braun Melsungen AG | ✓ | ◐ | ◐ | ◐ | ✓ | − |
| Stryker Corporation | ✓ | ◐ | − | ✓ | ✓ | ◐ |
| Smith & Nephew | − | ◐ | ✓ | ◐ | ◐ | ✓ |
| 3M Company | ◐ | − | − | ◐ | ◐ | − |
| ConMed Corporation | − | ◐ | ◐ | − | − | ◐ |
| Teleflex Incorporated | − | − | ◐ | − | ◐ | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Medtronic91
2Johnson & Johnson (Ethicon)78
3Stryker Corporation72
4B. Braun Melsungen AG68
5Smith & Nephew65
63M Company58
7ConMed Corporation54
8Teleflex Incorporated50
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
MedtronicJohnson & Johnson (Ethicon)
Challenger2
Strong scale, closing on the leaders.
B. Braun Melsungen AGStryker Corporation
Contender2
Focused players with pockets of strength.
Smith & Nephew3M Company
Niche2
Specialists in a single segment or region.
ConMed CorporationTeleflex Incorporated
Go-to-market strategy
Land Material in North America, then scale across Tissue Forcep Market — a $377M beachhead inside a $6.28B market.
Beachhead (SOM)$377Mobtainable near-term
Serviceable (SAM)$2.31Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion89 fit
Stainless Steel
Best fit — highest urgency & budget in Material.
Economic buyer79 fit
Titanium
Strong fit — clear ROI and a fast path to value.
End user64 fit
Plastic
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Material in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Tip Design & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Handle Type
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales46%
Partner / channel28%
Digital / self-serve19%
Marketplaces6%
Positioning & messaging
§GTM 2 · p.194 →For Material leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Tissue Forcep Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified43%
Sales qualified26%
Evaluation13%
Closed-won6%
$11.9KCAC
$44KLTV
3.7:1LTV : CAC
< 3 moCAC payback
Investment thesis
Tissue Forcep Market is a resilient opportunity — $4.66B by 2033, compounding at 5.9%.
TAM · 2025$2.94Btoday
TAM · 2033$4.66Bforecast
CAGR5.9%2027–2033
Cumulative$33.7Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$4.66BTotal addressable market
SAM$1.90BServiceable available market
SOM$388MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →5.9% CAGR
Demand compounds through 2033, outpacing GDP across Material.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Material moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$4.66BLarge & growingTAM by 2033 at 5.9% CAGR
$1.90BServiceable nowreachable with today’s model
$388MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$3.64BBear3.8% CAGR
$4.66BBase5.9% CAGR
$5.97BBull7.8% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Tip Design optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
Tissue Forcep Market — a $806M market by 2033. Plan: grow share from 9.2% to 17.4%.
Market size · 2033$806Mtotal addressable
Market CAGR7.6%2027–2033
Target share17.4%from 9.2% today
Revenue ambition$140Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 9.2% | 17.4% | Ahead |
| Revenue | $80M | $140M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Behind |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 33.2% | 39.6% | At risk |
| Customer retention | 86.2% | 96.4% | Ahead |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Material
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Tip Design capability
A defensible second engine — invest in Tip Design to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Material share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Tip Design
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $17M capacity & capability investment
- Greenlight bolt-on M&A in Tip Design
- Authorise North America expansion plan
- Fund R&D program for Material leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossOn track
- Input-cost & supply riskOn track
- Regulatory / policy changeAt risk
- Execution & talentAhead
Sales deck · value proposition
Win the Tissue Forcep Market conversation — a $10.8B market you can size, segment and defend in minutes.
Market size · 2033$10.8Btotal opportunity
Growth10.1%CAGR to 2033
Addressable buyers1,001+accounts in scope
Typical ROI4.3×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Material
Goal Grow share in Material
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.3×return on cost, year one
< 4 mopayback period
$78K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
MedtronicJohnson & Johnson (Ethicon)B. Braun Melsungen AGStryker CorporationSmith & Nephew3M CompanyConMed CorporationTeleflex Incorporated+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Tissue Forcep Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Tissue Forcep Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Pharma and Healthcare · scroll →Alumina Substrate for Chip Resistor Market
Market size, share, segmentation and regional forecast.
$5.3B by 2033 · 7.30% CAGR
View reportOtoscopes Market
Market size, share, segmentation and regional forecast.
$5.8B by 2033 · 4.46% CAGR
View reportRespiratory Drug Market
Market size, share, segmentation and regional forecast.
$795M by 2032 · 7.18% CAGR
View reportFucoxanthin Market
Market size, share, segmentation and regional forecast.
$7.8B by 2032 · 3.61% CAGR
View reportOrally Disintegrating Tablets Market
Market size, share, segmentation and regional forecast.
$3.6B by 2031 · 4.04% CAGR
View reportTuberculosis Drugs Market
Market size, share, segmentation and regional forecast.
$12.9B by 2032 · 8.73% CAGR
View reportOver-the-Counter Drug Market
Market size, share, segmentation and regional forecast.
$6.3B by 2032 · 8.68% CAGR
View reportAlpha Galactosidase A Market
Market size, share, segmentation and regional forecast.
$13.9B by 2032 · 8.22% CAGR
View reportTransdermal Drug Delivery Systems Market
Market size, share, segmentation and regional forecast.
$2.9B by 2032 · 4.78% CAGR
View reportRosuvastatin Market
Market size, share, segmentation and regional forecast.
$13.4B by 2031 · 5.72% CAGR
View reportSystemic Lupus Erythematous SLE Drug Market
Market size, share, segmentation and regional forecast.
$9.1B by 2032 · 5.67% CAGR
View reportAllergic Conjunctivitis Drugs Market
Market size, share, segmentation and regional forecast.
$4.8B by 2033 · 3.57% CAGR
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report ships as a formatted PDF, a fully editable XLSX containing all underlying data tables, and a presentation-ready PPT deck - so you can re-chart, re-model, or drop any figure straight into your own deck.